Total amount raised
$1.7 Billion
Latest funding date
4/1/2024
Location
PharmEasy has successfully raised funds through 15 rounds, with the latest being debt financing led by 360 ONE Asset. The platform connects users to local pharmacies and labs, offering medicine delivery and diagnostic services.
With 57 investors backing its growth, including Micro Labs and Bennett Coleman and Co Ltd, PharmEasy continues to expand its reach in the healthcare sector. Keep reading to explore the intricacies of PharmEasy's fundraising journey and the investors supporting this innovative platform.
What Is PharmEasy?
PharmEasy, based in Mumbai, Maharashtra, India, is a prominent online health service that connects users to local pharmacies and labs for medicine delivery and diagnostic services. The company operates in multiple industries, including E-Commerce, Health Care, Health Diagnostics, Pharmaceutical, and Wellness.
Founded with the mission to make healthcare accessible and affordable, PharmEasy has grown significantly, employing between 5001-10000 people. The platform offers a wide range of services, including doctor consultations, lab tests, and a variety of healthcare products, ensuring comprehensive care for its users.
How Much Funding Has PharmEasy Raised?
- Debt Financing
- Amount Raised: INR 17,000,000,000
- Date: September 2025
- Lead Investors: 360 ONE Asset
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand business operations and enhance technology.
- Private Equity
- Amount Raised: INR 18,040,000,000
- Date: April 2024
- Lead Investors: MEMG Family Office
- Valuation at Round: $710 million
- Motivation Behind the Round: To repay debt taken from Goldman Sachs.
- Private Equity
- Amount Raised: Not publicly disclosed
- Date: January 2024
- Lead Investors: Naspers, Temasek Holdings
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale up services and enter new markets.
- Debt Financing
- Amount Raised: Not publicly disclosed
- Date: November 2022
- Lead Investors: EvolutionX Debt Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To enhance technology and stabilize financials.
- Series Unknown
- Amount Raised: Not publicly disclosed
- Date: October 2021
- Lead Investors: Trifecta Capital Advisors
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand business operations.
- Series Unknown
- Amount Raised: $204,000,000
- Date: October 2021
- Lead Investors: Vestin Wolf Capital Management
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale up services and enhance technology.
- Series F
- Amount Raised: $500,000,000
- Date: July 2021
- Lead Investors: Arokiaswamy Velumani
- Valuation at Round: $5.6 billion
- Motivation Behind the Round: To expand business operations and enter new markets.
- Secondary Market
- Amount Raised: $20,000,000
- Date: June 2021
- Lead Investors: B Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To stabilize financials and enhance technology.
- Series E
- Amount Raised: $390,000,000
- Date: April 2021
- Lead Investors: Prosus Ventures, TPG Growth
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale up services and expand business operations.
- Series D
- Amount Raised: $220,000,000
- Date: November 2019
- Lead Investors: Temasek Holdings
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To enhance technology and enter new markets.
Total Amount Raised: $1,530,000,000
Current Valuation: $710 million
Key Investors
- Manipal Education and Medical Group (MEMG)
- Details: Led by Ranjan Pai, MEMG is a prominent player in the education and healthcare sectors. The group contributed Rs 800 crore in the recent funding round for PharmEasy.
- Investment Focus Areas: Education, healthcare.
- Notable Investments: Manipal Group of institutions.
- Prosus
- Details: Prosus is a global consumer internet group and one of the largest technology investors in the world. They invested Rs 221 crore in PharmEasy.
- Investment Focus Areas: Consumer internet, online classifieds, food delivery, fintech.
- Notable Investments: Tencent, Delivery Hero, OLX.
- Temasek
- Details: Temasek is a global investment company headquartered in Singapore. They invested Rs 183 crore in PharmEasy.
- Investment Focus Areas: Financial services, telecommunications, media, technology.
- Notable Investments: Alibaba, DBS Bank, Singapore Airlines.
- 360 ONE Asset
- Details: 360 ONE Asset is a leading asset management and financial services company. They were the lead investor in PharmEasy's debt financing round.
- Investment Focus Areas: Asset management, financial services.
- Notable Investments: Specific notable investments not mentioned.
- Goldman Sachs
- Details: Goldman Sachs is a global investment banking, securities, and investment management firm. They were part of the group that collectively invested Rs 400 crore in PharmEasy.
- Investment Focus Areas: Technology, healthcare, financial services.
- Notable Investments: Uber, Facebook, Spotify.
What's Next for PharmEasy?
PharmEasy stands at a pivotal juncture with significant opportunities on the horizon. The recent $216 million funding round, led by MEMG, provides a crucial lifeline to stabilize its financials and repay existing debt. This influx of capital positions PharmEasy to leverage the growing demand for online pharmacy services and expand its market reach.
Future fundraising opportunities appear promising, with the potential for additional rounds to further solidify its financial standing. If market conditions improve, PharmEasy might revisit its IPO plans, offering a pathway to substantial capital influx. Strategic partnerships and acquisitions could also play a vital role in enhancing its service offerings and market position.
However, challenges remain. The company must navigate the aftermath of a significant valuation drop and manage substantial debt. Restoring investor confidence and maintaining operational efficiency will be critical as PharmEasy aims to capitalize on industry trends and growth opportunities in the online healthcare sector.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like PharmEasy and gather other critical business insights.
Sign up for free to start exploring the wealth of information available at your fingertips.
